Loading
IOS subscription app for people on peptides, GLP-1s and TRT protocols. Users log doses on a reminder calendar, upload bloodwork with automatic out-of-range flagging, track body metrics and progress ph. Ansar recorded MRR $6, revenue (30d) $17 and lifetime revenue $17.
A sale listing signals the founder’s own read on the business; backed by a read-only payment-provider sync.
Strongest verification behind this event, aged, and discounted by how sure we are it belongs to this company.
How much this moves the ecosystem, independent of your interests.
Share of marketing vocabulary detected in the headline and summary.
Distinct kinds of checkable fact found: amounts, versions, measured changes.
These are Ansar’s estimates, not source claims. The summary above was assembled from source text, not generated.
iOS subscription app for people on peptides, GLP-1s and TRT protocols. Users log doses on a reminder calendar, upload bloodwork with automatic out-of-range flagging, track body metrics and progress ph